Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Sergeeva, A. Emelyanov, O. Korovina, A. Znakhurenko, E. Leshenkova (Saint-Petersburg, Russian Federation). Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma. Eur Respir J 2014; 44: Suppl. 58, 1767

Member's Comments

No comment yet.

Related content which might interest you: Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly? Source: International Congress 2014 – COPD exacerbations Year: 2014 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Diabetes and hospitalization for COPD exacerbation Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Impact of bronchiectasis on the course of COPD Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 LATE-BREAKING ABSTRACT: Evaluation of symptoms and risk on stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis Source: International Congress 2014 – Predictors Year: 2014 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014